Description: Elixinol Global Limited engages in the industrial hemp and medicinal cannabis business in Australia. It manufactures and distributes industrial hemp-based dietary supplements and foods, and skincare products; and medicinal cannabis. The company is based in Sydney, Australia.
Home Page: www.elixinolwellness.com
680 George Street
Sydney,
NSW
2000
Australia
Phone:
61 2 4044 4585
Officers
| Name | Title |
|---|---|
| Mr. Ronald Dufficy BEC, FCPA | Interim Global Chief Exec. Officer |
| Ms. Josephine Lorenz | Global CFO & Group Financial Controller |
| Glen Zurcher | Account Director of Investor Relations Department |
| Ms. Teresa Cleary | Gen. Counsel & Company Sec. |
| Mr. Rob Hasselman | Pres of Americas |
| Ms. Beata Silber | Global Head of R&D and Innovation |
| Ms. Kim Bradley-Ware | Joint Company Sec. |
Exchange: OTCQB
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7164 |
| Price-to-Sales TTM: | 0.5907 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |